EUDAW EUDA Health Holdings Ltd

Price Chart

Executive Summary

EUDA Health Holdings Ltd terminated its At The Market Offering Agreement with Chardan Capital Markets, effective July 22, 2026, and suspended the ATM offering as of June 10, 2026. No shares were ever sold under the agreement, which had authorized up to $10,000,000 in ordinary shares. This removes a potential future dilution overhang for warrant holders (EUDAW).

Actionable Insight

Key Facts

• EUDA terminated the ATM Agreement with Chardan Capital Markets on June 5, 2026, effective July 22, 2026.
• The ATM offering was suspended as of June 10, 2026.
• No ordinary shares were ever sold under the ATM Agreement or the Filed Prospectus Supplements.
• The ATM Agreement had authorized up to $10,000,000 in ordinary shares.
• The company will file a prospectus supplement reducing the number of shares offered to zero.

Financial Impact

Removes potential dilution of up to $10,000,000 in ordinary shares, which would have been dilutive to both common and warrant holders. No actual dilution occurred.

Risk Factors

• The company may seek alternative financing that could be more dilutive or on worse terms.
• The termination does not address the company's underlying cash needs or financial health.

Market Snapshot

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status

Related Tickers